Fact-checked by Grok 2 weeks ago

Pregnancy test


A pregnancy test is a diagnostic procedure that detects the hormone human chorionic gonadotropin (hCG) in urine or blood samples to ascertain pregnancy, with hCG produced by trophoblastic cells of the implanted embryo shortly after fertilization. Home urine-based tests, which rely on immunoassay strips to bind and visualize hCG, became widely available in the late 1970s following the invention of the first such device in 1967 by Margaret Crane while working at Organon Pharmaceuticals. These tests detect hCG levels typically rising to detectable thresholds (around 25 mIU/mL for most kits) within 10-14 days post-ovulation, enabling early confirmation before a missed menstrual period. Blood tests conducted in clinical settings offer greater sensitivity, quantifying hCG concentrations to distinguish viable pregnancies, ectopic implantations, or multiples. Manufacturers claim over 99% accuracy for urine tests when used correctly after the expected period, though real-world sensitivity varies by brand and timing, with false negatives more common early due to insufficient hCG and rare false positives from conditions like molar pregnancies or certain medications. Prior biological assays, such as the 1931 Friedman rabbit test, required animal sacrifice and laboratory facilities, marking a shift to accessible, non-invasive methods that prioritize empirical detection over historical proxies like urinary wheat germination.

Biological Basis

Human Chorionic Gonadotropin (hCG) Detection

(hCG) is a consisting of alpha and beta subunits, synthesized and secreted primarily by cells of the developing following embryonic implantation into the uterine wall. Production begins shortly after implantation, which typically occurs 6 to 10 days post-fertilization, enabling hCG to maintain the and support progesterone secretion essential for early sustenance. Levels rise exponentially, doubling approximately every 48 to 72 hours in the first weeks, before peaking at around 100,000 mIU/mL between 8 and 11 weeks of , after which they decline and stabilize. hCG exists in multiple molecular variants, including intact dimeric hCG, free beta-subunit (β-hCG), nicked forms, and hyperglycosylated hCG (hCG-H), the latter predominant in early implantation and produced by cells to promote and immune . Pregnancy tests primarily detect the beta-subunit due to its specificity, though assays vary in sensitivity to these forms; for instance, most over-the-counter urine tests target thresholds of 20 to 25 mIU/mL for intact hCG or total β-hCG, while highly sensitive serum assays can detect as low as 1 to 2 mIU/mL. Hyperglycosylated hCG, comprising up to 50% of total hCG in the first weeks, is crucial for but diminishes after 10 to 11 weeks. Empirically, hCG becomes detectable in maternal 8 to 10 days after in viable pregnancies, reflecting post-implantation , with detection lagging by 1 to 2 days due to renal filtration and concentration dynamics, typically 10 to 12 days post-. This timeline aligns with implantation , where hCG secretion initiates and vascular remodeling at the maternal-fetal interface, though variability exists based on implantation site and viability. Quantitative measurements confirm levels exceed 5 mIU/mL by day 10 post- in most cases, providing a biochemical for successful nidation.

Types of Tests

Urine-Based Tests

Urine-based pregnancy tests, the predominant method for at-home detection, utilize lateral flow immunoassay strips that detect (hCG) in through specific binding by monoclonal antibodies targeted at the beta subunit of the hormone, resulting in a visible color change or line formation if hCG exceeds the test's threshold. These tests incorporate absorbent materials that wick across a where immobilized antibodies capture hCG, and a second set of enzyme-conjugated antibodies produces a detectable signal, minimizing with other hormones due to the antibodies' selectivity. Variations include or strip formats, which require immersion in a collected sample, and midstream wands designed for direct urine stream application to simplify handling; both rely on interpreting and test lines, though midstream types often show higher user accuracy in studies. Digital variants process the result electronically to display words like "pregnant" or "not pregnant," reducing subjective errors compared to line-based readouts, while maintaining comparable . Sensitivity has advanced significantly since the , when over-the-counter tests typically required hCG levels of 25–50 mIU/mL for detection, to modern thresholds below 10 mIU/mL, enabling claims of positive results up to six days before the expected missed period; for instance, First Response Early Result achieves an analytical sensitivity of 6.3 mIU/mL, detecting over 95% of pregnancies on the day of the missed period and approximately 76% five days prior in laboratory evaluations. tests dominate consumer markets, accounting for roughly 90% of pregnancy confirmations in the United States due to their accessibility, low cost, and over-the-counter availability without medical oversight.

Blood-Based Tests

Blood-based pregnancy tests measure (hCG) levels in serum obtained via , typically processed through (ELISA) or chemiluminescent techniques in clinical laboratories. These tests are categorized into qualitative assays, which detect the presence or absence of hCG above a (yielding a yes/no result), and quantitative assays, which provide precise numerical values of beta-hCG concentration in milli-international units per milliliter (mIU/mL). Qualitative tests function similarly to urine-based methods but with enhanced reliability in low-concentration scenarios, while quantitative tests enable serial monitoring to evaluate pregnancy progression. Quantitative blood tests offer superior , detecting hCG levels as low as 1-2 mIU/mL, compared to tests' typical threshold of 20-25 mIU/mL, allowing detection as early as 7-12 days post-ovulation. This precision makes them the preferred confirmatory method in hospital settings for early or ambiguous cases, such as suspected or non-viable pregnancies. Serial quantitative measurements track hCG dynamics, with viable intrauterine pregnancies exhibiting a of approximately 48-72 hours in the first 6-8 weeks. In clinical practice, blood tests serve as the gold standard for investigating ectopic or pregnancies, where hCG patterns deviate from norms—ectopic cases often show slower rises or plateaus (with normal doubling in only about 64% initially), and pregnancies may present with markedly elevated levels exceeding expected gestational norms. These assays require professional and laboratory analysis, limiting them to medical facilities rather than home use, but their accuracy supports definitive diagnosis when findings are inconclusive.

Ultrasound and Imaging Methods

imaging provides direct visualization of pregnancy structures, serving as a confirmatory tool following positive hormonal tests to assess location, viability, and . Transvaginal (TVUS), using an intravaginal probe, offers higher resolution for early detection compared to abdominal , which employs an external transducer over the abdomen. TVUS can identify the gestational sac as early as 4.5 to 5 weeks gestation from the last menstrual period (LMP), with the yolk sac appearing around 5 to 6 weeks and the fetal pole with cardiac activity detectable by 5.5 to 6 weeks LMP. Abdominal ultrasound typically visualizes the later, around 6 to 7 weeks LMP, due to lower sensitivity in early stages, making TVUS the preferred modality for first-trimester confirmation. In clinical practice, is employed after elevated beta-hCG levels to verify an intrauterine pregnancy, distinguish viable from non-viable gestations, and exclude ectopic pregnancies, particularly when hCG trends are inconclusive. Detection of fetal cardiac motion by 6 to 7 weeks strongly predicts ongoing viability, with absence potentially indicating or anembryonic pregnancy. Despite its diagnostic utility, ultrasound interpretation is operator-dependent, with accuracy influenced by technician skill and equipment quality, potentially leading to subjective errors in identifying subtle early features. is constrained by the need for specialized facilities and trained personnel, rendering it unsuitable for initial screening in low-resource settings or as a primary pregnancy test due to higher costs and logistical barriers compared to or assays. Routine use is thus reserved for secondary evaluation rather than universal early detection.

Procedure and Interpretation

Optimal Timing and Sensitivity Thresholds

Home urine pregnancy tests detect (hCG) once levels rise sufficiently following blastocyst implantation, which typically occurs 6 to 10 days after fertilization, though variability can extend this window up to 12 days. hCG production begins immediately post-implantation and doubles approximately every 48 to 72 hours, reaching detectable thresholds in urine by the time of expected menses in most cases. Testing before this rise risks false negatives due to insufficient hCG, with studies indicating that even sensitive assays may miss early pregnancies if performed prior to the missed period. The optimal timing for reliable results is on or after the first day of a missed period, when hCG levels generally exceed 25 mIU/mL in pregnant individuals with regular cycles, allowing most over-the-counter tests to achieve detection rates above 95%. For tests with higher analytical , such as those detecting 6.3 mIU/mL, positive results can occur up to 6 days before the missed period, but accuracy improves post-menses due to reduced variability in hCG accumulation. Less sensitive tests (25-50 mIU/mL threshold) may require waiting 1-2 days after the missed period to minimize non-detection. Irregular menstrual cycles complicate timing, as the missed period serves as the primary marker; in such cases, serial testing or blood assays are recommended to account for delayed and implantation. Urine concentration significantly influences detection, with first-morning void preferred due to lower dilution and higher relative hCG levels overnight, enhancing test by up to 20-50% compared to afternoon samples in early . Dilute urine from excessive fluid intake can lower effective hCG concentration below test thresholds, particularly for borderline levels around implantation. Empirical data from validation studies confirm that sensitive tests (≤12.5 mIU/mL) yield 99% accuracy from the day of expected menses when using concentrated urine, underscoring the interplay of timing, , and sample quality.

Step-by-Step Usage Guidelines

For urine-based home pregnancy tests, begin by verifying the on the package and reviewing the specific instructions provided by the manufacturer, as variations exist among brands. Collect a sample using a clean, dry container if dipping the strip, or hold the absorbent end directly in the urine stream for the recommended duration, typically 5-10 seconds, to ensure adequate absorption. Avoid excessive fluid intake prior to testing to prevent dilution of the sample, which can compromise result validity. Place the test strip on a flat, non-absorbent surface and wait the specified time, usually 1-5 minutes, for the reaction to develop; do not interpret results outside this window to avoid lines. Validate the test by confirming the appearance of a , indicating proper function; absence of this line signifies an invalid result, necessitating a retest with a new device. A visible test line alongside the control line denotes a positive result, while only the control line indicates negative; any positive outcome should be confirmed via clinical or consultation with a healthcare provider. Digital urine tests follow analogous protocols for sample collection and waiting periods but display results as words (e.g., "pregnant" or "not pregnant") rather than lines, potentially reducing subjective interpretation errors. Some models integrate with applications for result logging and tracking, facilitating record-keeping without altering the fundamental hCG detection mechanism or improving core accuracy over non-digital equivalents. Retest invalid digital results promptly, and adhere to manufacturer guidelines for or device functionality.

Accuracy Metrics

Sensitivity, Specificity, and Empirical Error Rates

, the true positive rate, measures a pregnancy test's ability to correctly detect (hCG) in pregnant individuals, calculated as true positives divided by the sum of true positives and false negatives. Specificity, the true negative rate, measures correct identification of non-pregnancy, calculated as true negatives divided by true negatives plus false positives. These metrics vary by test type, hCG threshold, and timing relative to conception or missed period. Over-the-counter urine pregnancy tests, designed to detect hCG at or above 25 international units per liter (IU/L), achieve of 97% to 99% when used on or after the day of the expected menstrual period, with specificity exceeding 99% in controlled conditions. A and of self-testing reported near 100% at these thresholds under ideal conditions, though real-world user application reduced to approximately 91% (95% : 84%-96%) due to procedural variations. Blood-based tests demonstrate superior early-detection compared to urine tests, identifying hCG as low as 5-50 /L 7-12 days post-conception versus 's typical 10-14 days. Qualitative tests yield both above 99% in clinical settings, outperforming in low-hCG scenarios. Empirical studies reveal overall accuracy of 97%-99% for home tests when instructions are followed post-missed , but real-world error rates rise with early testing or user factors, including false negative rates of 1%-5% from suboptimal hCG levels or timing. In point-of-care testing, false negative omission rates approximate 1.6% across large cohorts, underscoring a gap between manufacturer claims and practical performance.

Factors Influencing Test Outcomes

Biological factors can significantly alter pregnancy test outcomes by interfering with hCG detection mechanisms. , an immunological phenomenon, arises when excessively high hCG concentrations—such as those in multiple gestations or —saturate the test's antibodies, preventing proper binding and yielding false negatives despite pregnancy presence. This occurs because excess disrupts the antigen-antibody complex formation essential for signal generation, typically at hCG levels exceeding 500,000–1,000,000 mIU/mL. Empirical observations indicate this effect is rare in routine testing but documented in cases of or advanced multiples. Certain medications introduce exogenous hCG or analogous substances that mimic or boost detectable levels, thereby influencing results independently of endogenous production. Fertility drugs like Pregnyl or Novarel, which contain synthetic hCG for , can trigger positives in non-pregnant users by elevating urinary hCG for up to 10–14 days post-administration. Other pharmaceuticals, including some anti-epileptics or heterophilic antibody-inducing agents, may rarely cross-react with antibodies, though peer-reviewed data emphasize hCG-based therapies as the primary culprits. Clinical guidelines from institutions like the confirm that only hCG-containing medications reliably interfere, underscoring the need for timing tests post-treatment cessation. User and environmental variables often stem from sample handling or test integrity, reducing assay reliability through non-biological means. Urine dilution from excessive fluid intake lowers hCG concentration relative to test sensitivity thresholds (typically 20–25 mIU/mL for over-the-counter kits), potentially masking early pregnancies; first-morning urine, with higher specific gravity, mitigates this by concentrating hCG 2–5 fold. A study on physiological dilution found that while sensitive tests retain detection up to fivefold dilution, borderline hCG levels (<50 mIU/mL) yield higher miss rates, linking 5–10% of early false negatives to status rather than test defects. Test kit expiration and improper storage degrade immunoreactive components, impairing function and elevating error risks. Beyond printed dates (usually 1–3 years), exposure to temperatures above 30°C or accelerates breakdown, with FDA analyses noting increased false negatives from compromised control lines. Manufacturers recommend cool, dry storage to preserve sensitivity, as heat-induced denaturation can halve detection efficacy even in unexpired kits, per stability studies. Empirical user surveys correlate ~2–5% of reported inaccuracies to these factors, distinct from inherent limits.

Sources of Error

False Positive Causes and Incidence

False positives on urine-based pregnancy tests, which detect (hCG), occur when the test indicates pregnancy in the absence of a viable or ongoing . One primary cause is residual hCG from a recent or , where levels can persist in for 1 to 5 weeks post-loss, leading to detectable positives despite no current pregnancy. Chemical pregnancies, defined as very early embryonic losses before 5 weeks where implantation occurs but development ceases, also produce transient hCG sufficient for a positive test, often mistaken for a false positive if retesting occurs after the loss. These account for an estimated 20-25% of spontaneous conceptions and up to 30% in assisted reproduction cycles, with studies indicating that 25-30% of early positive tests do not progress to viable pregnancies. Exogenous hCG administration, such as from fertility medications like Pregnyl, Profasi, or Novarel used in treatments for , directly elevates hCG levels and can cause positives for days to weeks after injection. Rare medical conditions involving hCG secretion include (e.g., ), ectopic pregnancies with persistent hCG, and nongestational tumors such as germ cell tumors, choriocarcinomas, or certain lung/ovarian cancers, which produce beta-hCG mimicking pregnancy signals. Interfering substances, including heterophilic antibodies (e.g., human anti-mouse antibodies or ), upper urinary tract infections causing interference, or older medications like phenothiazines, can trigger false readings in tests, though these are uncommon with modern assays. The overall incidence of true false positives—excluding recent pregnancy losses—is low, estimated at less than 1% for home urine tests in non-pregnant individuals, with clinically significant cases in hCG assays occurring in 1 per 1,000 to 1 per 10,000 tests. Rates rise to 5 per 1,000 in some older studies of biological tests but remain rare in contemporary over-the-counter kits, particularly in low-risk populations without treatments. Post-fertility therapy, incidence increases due to injected hCG, potentially affecting up to several weeks of testing; in pediatric or cancer patients with interfering factors like , rates can reach 57% in small series, though this is not representative of general use. Empirical data from clinical cohorts show that approximately 50% of positives detected before the expected menstrual period may reflect non-viable outcomes upon follow-up, underscoring the need for confirmation via quantitative hCG trends or to distinguish true positives from erroneous ones.

False Negative Causes and Incidence

The primary cause of false negative results in home pregnancy tests is testing before (hCG) levels reach detectable thresholds, typically occurring when implantation has not yet produced sufficient hormone or when testing precedes the expected missed period by several days. hCG production begins after implantation, around 6-12 days post-ovulation, and doubles approximately every 48 hours in early , but levels vary widely among individuals. Empirical data indicate false negative rates as high as 20% on the first day of a missed period due to these low initial concentrations, dropping to under 5% one week later with sensitive tests detecting 20-25 mIU/mL hCG. Excessive fluid intake prior to testing can dilute , reducing hCG concentration below the test's and yielding false negatives, particularly in early when levels are borderline. Manufacturers recommend using first-morning , which is naturally more concentrated, to minimize this risk. Studies confirm that physiological dilution from hydration does not typically cause errors in established pregnancies but can contribute in cases of marginal hCG elevation. Less common causes include use of tests with lower sensitivity (e.g., thresholds above 50 mIU/mL), which fail to detect pregnancies with slower hCG rises, and the rare "," where extremely high hCG levels in advanced pregnancies, multiples, or pregnancies saturate antibodies, preventing proper binding and resulting in false negatives. The is documented primarily in case reports and occurs in fewer than 1% of instances, often resolvable by diluting the sample. Overall false negative incidence post-missed period is under 1% with proper timing and sensitive assays, though user errors in timing account for most discrepancies in clinical reviews. Serial testing every 2-3 days is advised if is suspected despite a negative result, as hCG trajectories confirm viability in over 97% of cases by one week post-missed period.

Limitations and Criticisms

Detection of Non-Viable Pregnancies

Home pregnancy tests, capable of detecting (hCG) levels as low as 6.3–25 milli-international units per milliliter, can identify biochemical pregnancies, defined as implantations confirmed by elevated hCG without subsequent clinical viability, such as detectable on . These occur when embryonic development arrests shortly after implantation, often due to chromosomal abnormalities, resulting in hCG decline without menstruation delay or symptoms beyond a brief positive test. Empirical data from prospective studies indicate biochemical pregnancies comprise 20–30% of all conceptions detected via sensitive hCG assays, with one of 198 hCG-positive cases finding 22% resolving prior to clinical recognition. In the context of home testing, approximately 25–30% of early positive results fail to progress to viable pregnancies, reflecting the high frequency of these subclinical losses in natural cycles. Large-scale data corroborate this, showing 18–22% of positive hCG tests in assisted ending as biochemical losses, though rates may vary slightly in unassisted conceptions due to selection biases in reporting. The detection of such non-viable pregnancies via sensitive tests offers early awareness, potentially enabling prompt medical follow-up, but raises concerns about inducing psychological distress over losses that would otherwise remain undetected and asymptomatic. Critics contend this amplifies grief for common physiological events—estimated at 13–22% incidence across types—without altering outcomes, as most biochemical losses resolve spontaneously without intervention. However, no longitudinal studies demonstrate causal harm from test-induced knowledge alone, distinguishing informational awareness from pathological effects; empirical reviews emphasize that while anxiety may transiently increase, it does not correlate with long-term detriment beyond baseline pregnancy-related stress. Proponents highlight the value in distinguishing viable from non-viable cases through serial hCG monitoring, avoiding conflation with false positives.

User Misinterpretation and Psychological Impacts

One common involves misinterpreting faint positive lines on line-based home pregnancy tests as negative results, with studies indicating that approximately one in four women misread such tests due to challenges in discerning subtle color intensities. In one evaluation, users misidentified 230 out of 478 positive samples as negative, often stemming from inadequate comprehension of instructions that emphasize any visible line as indicative of . Evaporation lines, which form when evaporates on the test strip after the specified reading window (typically 3-10 minutes), further contribute to confusion; these colorless or grayish streaks can mimic faint positives, leading some users to erroneously conclude . Misreading faint positives as negatives can result in delayed confirmation via repeat testing or clinical evaluation, potentially postponing early prenatal care and increasing risks associated with undiagnosed pregnancies. Conversely, mistaking evaporation lines for true positives may induce unwarranted emotional distress, including anxiety over unplanned pregnancy or health concerns, prompting unnecessary medical consultations. Instruction leaflets for these tests often score poorly on clarity and plain-language standards, exacerbating subjectivity in non-digital formats despite manufacturer guidelines to read results within the timed window. Digital pregnancy tests address these issues by displaying explicit words like "Pregnant" or "Not Pregnant," reducing misinterpretation rates compared to line-based analogs, though traditional tests remain prevalent due to . Critics argue that for home tests overemphasizes simplicity and 99% accuracy claims—typically validated under ideal lab conditions—while understating real-world user variability, including timing errors and visual subjectivity. Overall, these interpretive challenges highlight the need for user education on hCG threshold dynamics and prompt follow-up with healthcare providers for ambiguous outcomes.

Alternative and Complementary Uses

Diagnosis of Abnormal Pregnancies

Serial quantitative beta-hCG measurements play a critical role in diagnosing abnormal pregnancies, such as ectopic and molar pregnancies, by revealing atypical hCG doubling patterns that deviate from the expected exponential rise in viable intrauterine pregnancies, where levels typically double every 48 hours in early gestation. In ectopic pregnancies, which occur in 1% to 2% of all pregnancies, hCG levels often rise more slowly (e.g., less than 66% increase over 48 hours), plateau, or decline, prompting further evaluation. These patterns arise because ectopic implantation, most commonly in the fallopian tube, limits trophoblastic proliferation compared to normal uterine development. For molar pregnancies, characterized by abnormal placental tissue proliferation without a viable (complete mole) or with a (partial mole), serum hCG levels are markedly elevated, frequently exceeding 100,000 mIU/mL, far above typical values for . This hypersecretion reflects exuberant trophoblastic activity, aiding differentiation from other conditions, though is essential to confirm characteristic findings like absent fetal parts or "snowstorm" appearance in complete moles. Serial blood hCG testing, often every 48 hours, serves as the standard initial approach, with as an adjunct to visualize extrauterine gestation or molar features when hCG exceeds the discriminatory zone (typically 1,500–3,000 mIU/mL without visible intrauterine sac). Early detection via serial hCG monitoring enables timely intervention, such as for unruptured ectopics or evacuation for moles, substantially reducing risks like tubal rupture and hemorrhage, which account for significant first-trimester maternal morbidity. Studies indicate that proactive screening lowers rupture probability compared to expectant , preserving and averting in many cases. While this approach is life-saving, it can occasionally lead to heightened anxiety from provisional diagnoses in resolving pregnancies mimicking abnormalities, though such over-diagnosis remains infrequent given confirmatory . No single hCG threshold definitively diagnoses these conditions, underscoring the need for integrated clinical assessment to avoid misinterpretation.

Monitoring in Fertility Treatments

In assisted reproductive technologies such as fertilization (IVF), serial quantitative β-hCG measurements are employed post-embryo to evaluate implantation success and early embryonic viability, providing dynamic data beyond static pregnancy tests. Protocols typically initiate testing 9-14 days after , with repeat assessments every 48 hours to track the rate of rise, as β-hCG production from the developing should approximately double every 1.4-2.1 days in viable pregnancies during this window. Appropriate β-hCG doubling—defined as at least a 53% increase over 48 hours—correlates with viable intrauterine pregnancies, while subpar rises (e.g., less than 66% in some cohorts) predict higher risks of non-viable outcomes, with studies reporting predictive accuracies for live birth around 70-80% when combining initial levels and trends. This monitoring enables early identification of failing implantations, facilitating prompt clinical interventions such as additional diagnostics or counseling, which contrasts with single-point tests that lack temporal context for prognosis. Although serial β-hCG tracking outperforms isolated measurements in prognostic precision—evidenced by improved differentiation of normal versus abnormal trajectories—the process can exacerbate anxiety through repeated draws and exposure to potentially unfavorable trends, though empirical affirm its net clinical utility in optimizing outcomes.

Historical Evolution

Pre-Modern Detection Methods

The earliest documented pregnancy detection method originates from , circa 1350 BCE, as recorded in the Berlin Medical Papyrus. Women were directed to pour their urine daily onto separate bags containing and seeds, often mixed with dates and sand; of the seeds signaled pregnancy, with sprouting first indicating a male and a female, while no growth suggested non-pregnancy. Subsequent empirical evaluations, including small-scale modern experiments replicating the procedure, have revealed germination rates in pregnant women's urine exceeding those in non-pregnant controls—often around 70% accuracy for detecting pregnancy—likely due to unidentified urinary compounds stimulating seed growth, though the method lacked any understood causal mechanism and remained prone to inconsistencies from variables like seed viability and environmental factors. In , circa 400 BCE, Hippocratic medical traditions prescribed inserting an onion or bulb into the overnight; the detection of vegetable on the breath the next morning was interpreted as evidence of non-pregnancy, predicated on the erroneous belief that a barren womb permitted odor transmission while a pregnant one sealed itself. This sensory-based approach offered no objective metrics, relying instead on subjective olfaction, and yielded unreliable results without empirical validation beyond anecdotal use. Medieval European practitioners, including 16th- and 17th-century "piss prophets" or uroscopists, assessed through of color, clarity, and sediment, sometimes tasting it or mixing with wine to observe or , positing that pregnant exhibited distinct turbid or frothy qualities. These qualitative folk techniques, disseminated in medical texts like those of (circa 1100 CE), suffered from inter-observer variability and absence of standardized criteria, resulting in high false-positive and false-negative rates, as no underlying physiological processes—such as hormonal markers—were recognized or measured. Overall, pre-modern methods depended on observational without causal insight into , rendering them inconsistent and non-reproducible compared to later hormone-based assays, though their persistence highlights early in bodily fluids.

Modern Scientific Developments (1920s–1970s)

In 1927, German scientists Selmar Aschheim and Bernhard Zondek developed the first reliable biological assay for pregnancy detection, known as the Aschheim-Zondek test, which identified (hCG) in urine by injecting samples into immature female mice; the presence of hCG induced ovarian changes such as follicle maturation and formation, confirming pregnancy with over 98% accuracy in clinical studies. This test marked a shift from unreliable pre-modern methods to empirical hormone-based diagnostics, though it required and laboratory expertise, limiting accessibility. By the 1930s, refinements included the use of frogs (Hogben test), where hCG triggered egg deposition within hours, reducing test time from days to under 24 hours and improving scalability for clinics. These bioassays dominated until the 1960s, when immunological methods emerged; in 1960, the hemagglutination inhibition (HI) test was introduced, using anti-hCG antibodies to detect hormone levels in urine via red blood cell agglutination, offering faster results without animals. Further advancement came in 1966 with A.R. Midgley's (RIA) for hCG, which employed radioactive-labeled antigens for precise quantification down to 25 IU/L, enabling earlier detection around 7-10 days post-conception but requiring specialized equipment due to radiation handling. Parallel to immunoassay progress, hormonal pregnancy tests like —containing and —were marketed in the UK and elsewhere from the late 1950s through the 1970s as oral diagnostics that induced withdrawal bleeding in non-pregnant women; however, retrospective meta-analyses and cohort studies have associated their use with elevated risks of congenital malformations, including limb reductions and defects, prompting withdrawals by 1978 amid safety concerns. These developments laid groundwork for quantitative hCG measurement, though early tests faced challenges like with and ethical issues with animal use.

Commercialization and Home Testing Era

The first over-the-counter home pregnancy test kits received U.S. (FDA) approval in 1976, marking a pivotal regulatory shift that classified these products as Class II medical devices requiring premarket clearance for substantial equivalence to existing assays. This approval enabled four initial kits—e.p.t. (early pregnancy test), Predictor, ACU-TEST, and —to enter the U.S. in , transitioning pregnancy detection from clinical settings to consumer self-testing. These early devices, often involving test tubes, droppers, and urine mixing with reagents to detect (hCG), required up to two hours for results and were designed for privacy, reflecting demands from advocates amid post-Roe v. Wade cultural changes. Commercial expansion accelerated through the late 1970s and 1980s, with pharmaceutical companies like Warner-Chilcott (e.p.t.) and (Predictor) scaling production for drugstore availability, reducing reliance on physician offices or labs that previously demanded appointments and fees. By the mid-1980s, iterative improvements lowered testing times to and enhanced sensitivity, though early kits exhibited limitations: positive results achieved approximately 97% accuracy, while negative results hovered around 80% due to thresholds detecting hCG only above 50-100 mIU/mL, risking false negatives in early pregnancies. Global dissemination followed, with kits reaching markets in and earlier via less stringent approvals, fostering broader access but highlighting variability in international regulatory standards. This era's innovations democratized testing, empowering individual agency in reproductive decisions while spurring market growth—home kits became the most common at-home diagnostic by the —but underscored technological constraints, as user errors in timing or interpretation compounded accuracy issues in non-clinical environments. Regulatory oversight via FDA's 510(k) pathway ensured baseline and , yet early commercialization faced critiques for incomplete instructions and gaps, prompting subsequent refinements without altering the foundational shift to consumer-led diagnostics.

Current Research and Innovations

Advances in Digital and Early-Detection Technologies

pregnancy tests, which employ readers to interpret hCG levels and results as "pregnant" or "not pregnant," have seen incremental enhancements since 2020 aimed at minimizing user misinterpretation of faint lines common in analog strips. These devices, exemplified by updated models, achieve over 99% accuracy from the day of expected and incorporate features like conception indicators in some variants, though core detection thresholds remain comparable to non-digital counterparts at around 10-25 mIU/mL hCG. Clinical evaluations indicate that such digital formats enhance user certainty, with studies reporting reduced false readings due to automated processing rather than visual . Post-2020 market expansions reflect growing adoption, with the global pregnancy test sector valued at USD 1.6 billion in 2024 and projected to reach USD 2.5 billion by 2037 at a CAGR of 6.9%, driven partly by trends and integration with consumer health tech. Innovations include smartphone-compatible apps for result logging and symptom tracking, such as those paired with tests like First Response PRO, which remind users of due dates and appointments, though direct hardware-app linkages for real-time hCG analysis remain limited to interpretive aids rather than novel sensors. trials post-2020 affirm high satisfaction rates, often exceeding 99% for ease of use, but emphasize no substantial gains in analytical sensitivity over traditional tests. Early-detection technologies have advanced through refined strip sensitivities, enabling urine-based identification of hCG as low as 6 mIU/mL in select models like First Response Early Result, allowing testing up to 6 days before a missed period with approximately 50-77% accuracy at that stage. These ultra-sensitive strips leverage improved monoclonal antibodies for hCG binding, yet empirical data from comparative trials show they do not surpass blood tests' lower thresholds (1-5 mIU/mL) and risk higher false negatives in low-hCG scenarios due to variability in urine concentration. Market analyses attribute a 5-7% CAGR in early-detection segments to heightened reproductive planning demands, though innovations prioritize reliability over revolutionary sensitivity leaps.

Ongoing Studies on Accuracy and Safety

Recent meta-analyses in the 2020s have examined the of (hCG) administration in assisted reproduction, such as intrauterine for recurrent implantation failure, finding it generally safe with no significant increase in adverse maternal or fetal outcomes when used adjunctively, though for routine remains limited. These reviews reaffirm hCG's biological safety profile, as elevated endogenous levels during pregnancy do not inherently cause defects absent underlying pathologies, but underscore the need for precise dosing to avoid complications like ovarian hyperstimulation. Large-cohort studies have mapped hCG trajectories to enhance predictive accuracy for viability, with analyses of IVF pregnancies showing that serial β-hCG measurements from days 1–4 post-transfer reliably forecast live birth rates, exhibiting slower rises in non-viable cases. Complementary on natural conceptions demonstrates that hCG doubling times and peak levels correlate with outcomes, enabling earlier differentiation of ectopic or failing pregnancies, though thresholds vary by gestational dating method. Controversies persist regarding historical hormone pregnancy tests (HPTs), such as used in the mid-20th century, with a 2024 UK parliamentary briefing concluding insufficient causal evidence linking them to birth defects despite associations in some cohorts. Independent meta-analyses, however, report statistically significant correlations between these synthetic progestogen-based tests and congenital malformations, prompting calls for re-evaluation amid claims of prior evidential suppression. Separately, non-invasive prenatal testing (NIPT) false positives, occurring in up to 93% of cases for rare trisomies, raise ancillary concerns about heightened parental anxiety and potential over-caution in interpreting confirmatory hCG-based tests, though direct spillover to early pregnancy detection accuracy remains unquantified. Emerging research focuses on integrations for superior accuracy and speed, including electrochemical point-of-care devices achieving quantitative hCG detection in within minutes, surpassing traditional lateral flow assays in for early . metasurface s and optics are under development to enable label-free, hCG quantification, potentially reducing false negatives in low-concentration scenarios. Data gaps persist in self-testing , with systematic reviews indicating high but limited outside post-abortion contexts, where confirmatory rates exceed 90% with free access yet drop without, highlighting needs for broader outcome tracking on unintended delays or misinterpretations in routine use.

References

  1. [1]
    Human Chorionic Gonadotropin - StatPearls - NCBI Bookshelf - NIH
    Apr 27, 2025 · Human chorionic gonadotropin (hCG) is a hormone produced by trophoblast tissue, which is typically found in early embryos and eventually develops into part of ...
  2. [2]
    Pregnancy Test: When To Take, Types & Accuracy - Cleveland Clinic
    Pregnancy tests work by checking your pee or blood for human chorionic gonadotropin (HCG), a hormone your body makes if you're pregnant. At-home tests are ...
  3. [3]
    Predictor Pregnancy Test | National Museum of American History
    Margaret Crane, the inventor of the first home pregnancy test, worked as a graphic designer for Organon, a pharmaceutical company in West Orange, New Jersey.
  4. [4]
    HCG pregnancy test: How it works and what the results mean
    An HCG pregnancy test checks human chorionic gonadotropin (HCG) levels in the blood or urine. It can detect elevated HGC levels and determine whether a person ...What is HCG? · Types of test · Accuracy · False results
  5. [5]
    Home pregnancy tests: Can you trust the results? - Mayo Clinic
    Dec 23, 2022 · Many home pregnancy tests claim to be 99% accurate. But home pregnancy tests differ in their ability to find a pregnancy in people who have recently missed a ...
  6. [6]
    Accuracy of Home Pregnancy Tests and New Developments - PMC
    Many home pregnancy tests claim to be more than 99 % accurate 26, when used from the day of the expected period. However, these accuracy figures are determined ...
  7. [7]
    Pregnancy Testing Through the Ages | myadlm.org
    Mar 1, 2020 · In 1927 a bioassay called the “A-Z Test” became the first test to determine a woman's pregnancy. The test worked by injecting a woman's urine ...
  8. [8]
    Biological functions of hCG and hCG-related molecules
    Aug 24, 2010 · From the time of implantation, hCG produced by trophoblast cells take over corpus luteal progesterone production rom luteinizing hormone (LH), ...
  9. [9]
    The Role of HCG in Implantation: A Mini-Review of Molecular ... - NIH
    Jun 19, 2017 · This mini-review aims to summarize the contribution of human chorionic gonadotropin (HCG) to implantation, and to present an overview of the clinical evidence.
  10. [10]
    Biochemistry and measurement in pregnancy and disease - UpToDate
    Jun 27, 2025 · Intact hCG (alpha/beta heterodimer) and free beta-subunit of hCG ... Hyperglycosylated hCG · - Pituitary hCG · LABORATORY MEASUREMENT OF hCG.
  11. [11]
    Hyperglycosylated hCG: a Unique Human Implantation and Invasion ...
    Dec 17, 2015 · The invasive extravillous trophoblast cells produce hCG-H during the very early stages, up to 10–11 weeks, of pregnancy.22, 23, 37, 38 The hCG-H ...Hcg And Potential Roles Of... · The Role Of Hcg-H In... · The Use Of Hcg-H As A...
  12. [12]
    β-Human Chorionic Gonadotropin Dynamics in Early Gestational ...
    Mar 7, 2024 · In spontaneously conceived singleton pregnancy, β-hCG becomes detectable in maternal serum as early as 8–10 days after ovulation in normal ...Missing: timeline | Show results with:timeline
  13. [13]
    The measurement of human chorionic gonadotropin for pregnancy ...
    Beginning shortly after implantation, approximately 8 days after presumed ovulation, HCG begins to rise rapidly, reaching a peak 8-12 weeks after the last ...Missing: timeline | Show results with:timeline
  14. [14]
    Urinary hCG patterns during the week following implantation - PMC
    1988), the intact protein first becomes detectable in the mother's blood and urine between 6 and 14 days after fertilization both in vitro and in vivo (Hay and ...Missing: timeline | Show results with:timeline
  15. [15]
    [PDF] Guidance for Over-the-Counter (OTC) Human Chorionic ... - FDA
    Monoclonal antibodies are highly sensitive to one specific site along the hCG molecule. If hCG is present in urine, it will be trapped by the anti- hCG ...
  16. [16]
    Pregnancy tests: a review - PubMed
    Pregnancy tests have now reached a level of sensitivity and specificity which is unlikely to be surpassed either by better tests or alternative technology.
  17. [17]
    Monoclonal antibody pregnancy tests - PubMed
    Their more selective binding properties allow detection of low levels of human chorionic gonadotropin (HCG) in the urine and serum.
  18. [18]
    Choose the Pregnancy Test Strip or Stick That's Right for You
    In contrast, stick tests offer various displays, including color changes, or digital readouts like “Yes” or “No” and “Pregnant” or “Not Pregnant.” Both ...Missing: midstream | Show results with:midstream<|separator|>
  19. [19]
    Sensitivity of over-the-counter pregnancy tests - PubMed - NIH
    The sensitivity of Clearblue Easy Earliest Results was 25 mIU/mL, which indicated detection of 80% of pregnancies. The sensitivity of the five other products ...
  20. [20]
    Natural Limits of Pregnancy Testing in Relation to the Expected ...
    Oct 10, 2001 · These reported assay detection limits of hCG range from 15 to 100 mIU/mL, with most kits between 25 and 50 mIU/mL. Detection limits for some ...
  21. [21]
    Pregnancy Testing Market Set to Reach USD 3.25 Billion by 2035 ...
    URINE-BASED HPT is very popular; investigations show that HPT is used to confirm around 90% of pregnancies in the United States of America. Currently, extensive ...
  22. [22]
    Pregnancy Tests | Urine and Blood | Everything You Need to Know
    A quantitative blood test measures the exact amount of hCG in the blood, and a qualitative hCG blood test gives a simple yes or no answer to whether you are ...<|separator|>
  23. [23]
    Pregnancy hGC Blood Tests: Accuracy, Benefits, Risks - Parents
    Mar 15, 2024 · The qualitative hCG blood test is about as accurate as a home urine test. A quantitative blood serum test is also known as the beta hCG test.
  24. [24]
    Blood Pregnancy Test: Types, Accuracy, and When It's Recommended
    This test can confirm pregnancy as early as 7 to 12 days after ovulation, and it is known for being more accurate than urine-based tests, particularly in cases ...Missing: advantages | Show results with:advantages
  25. [25]
    HCG Levels - 10 Things you need to know - Indira IVF
    Mar 12, 2024 · In a healthy pregnancy, hCG levels will roughly double up in 48 to 72 hours and keep on rising persistently till they peak at around 12 weeks of pregnancy.
  26. [26]
    What are HCG Levels? - American Pregnancy Association
    Typically, the hCG levels will double every 72 hours. The level will reach its peak in the first 8-11 weeks of pregnancy and then will decline and level off ...
  27. [27]
    Doubling time and hCG score for the early diagnosis of ectopic ...
    The doubling time of hCG and the hCG score are useful diagnostic aids in cases where transvaginal ultrasound has not (yet) given a definite answer.Missing: viable molar
  28. [28]
    Serial beta-hCG measurements in the early detection of ectopic ...
    A normal percentage increase and/or doubling time was observed in 64% of women who eventually proved to have an ectopic pregnancy. Ultimately, 85% of our ...
  29. [29]
    https://www.personalabs.com/blog/quantitative-or-qualitative-which-pregnancy-blood-test-should-you-take/
  30. [30]
    Role of ultrasound in the evaluation of first-trimester pregnancies in ...
    Transvaginal ultrasound is the modality of choice for establishing the presence of an intrauterine pregnancy; evaluating pregnancy viability, gestational age, ...
  31. [31]
    When Can You Hear Baby's Heartbeat? - Healthline
    Sep 26, 2018 · A fetal heartbeat may first be detected by a vaginal ultrasound as early as 5 1/2 to 6 weeks after conception. That's when a fetal pole, the ...
  32. [32]
    5 Weeks Gestation: What Should I See? - Sonosession
    By five weeks gestation, we are likely to see at least a gestational sac. With transvaginal ultrasound, an intrauterine pregnancy can usually be seen with a ...Measuring Mean Sac Diameter · Assessing Adnexa · First Follow Up Exam
  33. [33]
    Prospective comparison of vaginal and abdominal sonography in ...
    The study demonstrates through objective comparison that vaginal sonography is superior to abdominal sonography for detection of an intrauterine embryo and its ...
  34. [34]
    Early Weeks of Pregnancy: What Ultrasound Should Show
    Jan 22, 2014 · Around 6 or 7weeks, an abdominal ultrasound will show the gestational sac. A transvaginal ultrasound given at this time is likely to show images ...
  35. [35]
    Early Pregnancy Diagnosis - StatPearls - NCBI Bookshelf - NIH
    Jan 2, 2023 · ... urine test is a low beta-HCG urine level.[6] Beta-HCG can be quantified by testing 9 days after the luteinizing hormone peak.[5] False ...Missing: timeline ovulation
  36. [36]
    Liability, risks, and recommendations for ultrasound use in the ...
    Nov 4, 2023 · Ultrasound images can be subjective interpretations, and errors may occur due to factors such as operator skill, equipment limitations, or fetal ...
  37. [37]
    Artificial intelligence in obstetric ultrasound: A scoping review - Horgan
    Jul 28, 2023 · Obstetric ultrasound has several challenges, including its operator dependency, and its steep learning curve. Furthermore, access to adequately ...
  38. [38]
    Review Imaging fetal anatomy - ScienceDirect.com
    In addition to being subjective to fetal and maternal factors, ultrasound imaging is highly dependent on the skill of the operator and requires extensive ...<|control11|><|separator|>
  39. [39]
    Accuracy of home pregnancy tests at the time of missed menses
    It was estimated that a sensitivity of 12.5 mIU/mL was needed to detect 95% of pregnancies at the time of missing menses. Only 1 of 18 HPTs had this sensitivity ...
  40. [40]
    Sensitivity of Over-the-Counter Pregnancy Tests - ScienceDirect.com
    The sensitivity of Clearblue Easy Earliest Results was 25 mIU/mL, which indicated detection of 80% of pregnancies. The sensitivity of the five other products ...
  41. [41]
    Best Time of Day To Take a Pregnancy Test - Parents
    Jun 21, 2024 · Many experts recommend that you take a pregnancy test in the morning because first-morning urine contains the highest levels of hCG compared ...
  42. [42]
    How Does Taking a Pregnancy Test at Different Times of Day Affect ...
    In the earliest days of pregnancy, hCG levels are still very low, so getting a reliable result depends on how concentrated your urine is. The morning tends ...<|control11|><|separator|>
  43. [43]
    Pregnancy - FDA
    Apr 29, 2019 · For most home pregnancy tests, you either hold a test strip in your urine stream or you collect your urine in a cup and dip your test strip into ...
  44. [44]
    Pregnancy Test Instructions | Time to Conceive
    Point the absorbent tip (with 5 small openings) directly into the urine stream. Take the sample for at least 7-10 seconds, to ensure that an adequate sample is ...Missing: FDA | Show results with:FDA
  45. [45]
    Pregnancy Tests: When to Take One, Accuracy, and Results - WebMD
    Aug 5, 2025 · Use your first morning pee for the test. This is when your hCG levels are most concentrated and easily detected. · Don't drink a lot of fluids ...<|separator|>
  46. [46]
    Pregnancy testing | Better Health Channel
    Apr 14, 2022 · Early morning urine is concentrated and contains higher levels of hCG than at other times of the day. Most test strips indicate the presence of ...Missing: concentration | Show results with:concentration
  47. [47]
    [PDF] One step to early pregnancy detection - Cardinal Health
    1. Immerse the test strip into urine sample with the arrow end pointing down. Do not immerse the strip above the max dip line. Hold ...
  48. [48]
    Comparison of accuracy and certainty of results of six ... - PubMed
    Conclusions: The CBDPT was significantly better in terms of accuracy and certainty than non-digital OTC HPTs tested at a low hCG concentration. These results ...
  49. [49]
    Clearblue Digital Pregnancy Tests: Reliability, clarity, peace of mind
    May 27, 2024 · Digital pregnancy tests provide accurate results along with clarity and peace of mind. ... 99% accurate at detecting typical pregnancy ...Missing: traditional | Show results with:traditional
  50. [50]
    Are digital pregnancy tests more accurate than non-digital tests?
    Most home pregnancy tests, whether digital or non-digital, can claim around 99% accuracy when used on or after the day of a missed period ...
  51. [51]
    Self-testing for pregnancy: a systematic review and meta-analysis
    Feb 28, 2022 · Pregnancy self-testing is acceptable and valued by end users. Effectiveness data come mostly from articles on postabortion care, and cost data are lacking.
  52. [52]
    Diagnostic efficiency of home pregnancy test kits. A meta-analysis
    In studies where urine samples obtained by the investigators were tested by volunteers, sensitivity was 0.91 (95% confidence interval [CI], 0.84-0.96).
  53. [53]
    Substituting whole blood for urine in a bedside pregnancy test
    Overall, the whole blood pregnancy test was 95.8% sensitive (negative predictive value 97.9%), whereas the urine test was 95.3% sensitive (negative predictive ...
  54. [54]
    False negative point‐of‐care urine pregnancy tests in an urban ...
    May 1, 2021 · We found that POC urine pregnancy testing yielded a false negative omission rate of 1.6%. Because we included patients who had concurrent ...Missing: empirical | Show results with:empirical
  55. [55]
    False Negative Urine Pregnancy Test: Hook Effect Revealed - PMC
    The hook-effect is a rare but important phenomenon, rendering the kit tests false negative due to an improper antigen-antibody ratio.
  56. [56]
    The hook effect in pregnancy - MedicalNewsToday
    Feb 21, 2020 · High levels of hCG can overwhelm the antibodies that pregnancy tests use. When too much hCG is present in a sample, the antibodies may fail ...What is it? · In relation to pregnancy · Symptoms · Causes
  57. [57]
    [PDF] The hook effect - The Fetal Medicine Foundation
    In urine hCG tests, the hook effect is generally not observed until hCG concentrations reach 1,000,000 mIU/mL, as is seen in gestational trophoblastic disease.
  58. [58]
    What medications can cause a false positive pregnancy test?
    Mar 5, 2025 · Drugs that contain the hCG hormone aimed at boosting fertility may impact pregnancy test results. These may include: Pregnyl.
  59. [59]
    What can affect a pregnancy test result? - Clearblue
    Aug 6, 2025 · Drinking too many liquids can dilute your urine, making it more difficult for your home pregnancy test to detect the presence of hCG if it's ...
  60. [60]
    The effect of physiological urine dilution on pregnancy test ... - PubMed
    Despite a mean fivefold increase in urine dilution, the pregnancy tests with low betahCG detection limits maintained maximal sensitivity. The detection of ...
  61. [61]
    Do Pregnancy Tests Go Out of Date? - Community Health Centers
    May 31, 2024 · According to the FDA, pregnancy tests that are past their expiry date may provide false negative results more often than false positives.
  62. [62]
    https://shop.miracare.com/blogs/resources/do-pregnancy-tests-expire
  63. [63]
    False-positive pregnancy test: 6 possible causes - MedicalNewsToday
    Home pregnancy tests detect hCG in urine, but false positives can occur due to evaporation lines, substances in urine, or recent pregnancy loss.Missing: empirical | Show results with:empirical
  64. [64]
    What Does a Positive Pregnancy Test After a Miscarriage Mean?
    May 6, 2024 · However, it's common to get a positive pregnancy test after miscarriage for a week, two weeks, or even a month. This type of false positive ...
  65. [65]
    Chemical Pregnancy: Causes, Symptoms & Treatment
    A chemical pregnancy is a pregnancy loss that happens before the fifth week. Testing positive on a pregnancy test only to get a negative result a few weeks ...
  66. [66]
    Chemical Pregnancy – Symptoms and Tracking - Premom
    Aug 9, 2022 · A chemical pregnancy, or early pregnancy loss, happens to 30% of pregnancies following assisted reproduction and to 20-25% of spontaneously ...Missing: rate | Show results with:rate<|separator|>
  67. [67]
    8 Possible Causes for a False-Positive Pregnancy Test
    Jul 7, 2020 · 6. You're on medication with HCG in it. Let's start by saying this: Most medications won't affect the results of a pregnancy ...<|separator|>
  68. [68]
    Phyllodes Tumor: A Rare Cause of False-Positive Pregnancy Test ...
    Jan 7, 2025 · The most common causes of false positive pregnancy tests are operator error in performing or interpreting the test, biochemical pregnancy (loss ...<|separator|>
  69. [69]
    False-positive Urine Pregnancy Test Due to Leukocyte Interference
    Many factors can interfere with the test results and cause false-positives, including the presence of serum human anti-mouse antibodies (HAMA) and diseases ...
  70. [70]
    https://www.degruyterbrill.com/document/doi/10.1515/hmbci-2024-0080/html?lang=en
  71. [71]
    False Positive Pregnancy Tests and Phenothiazine - JAMA Network
    Phenothiazine compounds, which are known to produce false positive biological pregnancy tests, may also induce a false positive result in immunological tests ...
  72. [72]
    7 Reasons Your Pregnancy Test Gave A False-Positive - The Source
    Feb 1, 2021 · A false-positive test result only happens less than 1% of the time, but when it does, it can make the following days or weeks confusing before you realize you' ...
  73. [73]
    [Pregnancy tests. Can we trust them?] - PubMed
    False positive results occur in 5/1000 tests and can result from (CG) being ... test morning urine, which has the highest concentration of the hormone.
  74. [74]
    False-positive urine pregnancy screening tests are uncommon in the ...
    Case reports and small series of patients with BCUR have documented occurrences of false-positive UPST, even among males, with reported incidence as high as 57% ...
  75. [75]
    Avoiding Inappropriate Clinical Decisions Based on False-Positive ...
    ABSTRACT: Clinically significant false-positive human chorionic gonadotropin (hCG) test results are rare. However, some individuals have circulating factors in ...
  76. [76]
    What does a negative pregnancy test mean – and could it be a false ...
    Jan 27, 2025 · In fact, the FDA says up to 20% of pregnant women won't detect their pregnancy on the first day of their missed period – because of an ...
  77. [77]
    Can Water Intake Affect hCG Levels? - Pregnancy Tests - Parents
    Jun 24, 2024 · As a result, experiencing the type of "false negative" mix-up caused by diluted urine is likely to happen only very early on in your pregnancy.
  78. [78]
    The effect of physiological urine dilution on pregnancy test results in ...
    Jan 16, 2025 · This study addresses the likelihood of false negative urine pregnancy test results, due to physiological urine dilution as described in some ...
  79. [79]
    False Negative Urine Pregnancy Test: Hook Effect Revealed | Cureus
    Mar 2, 2022 · The hook-effect is a rare but important phenomenon, rendering the kit tests false negative due to an improper antigen-antibody ratio.Missing: incidence | Show results with:incidence
  80. [80]
    False negative and false positive pregnancy test results explained
    Jun 3, 2024 · Rest assured that if you tested from the day you expect your period, your Clearblue® test is over 99% accurate.1 Test again in 3 days' time, as ...Your Period · Ectopic Pregnancy · Early Pregnancy Loss
  81. [81]
    Biochemical Pregnancy During Assisted Conception: A Little Bit ...
    Jun 21, 2013 · A total of 107 (33.3%) of the 321 pregnancies identified by a positive hCG test miscarried either before (18.4%) or after (15%) the clinical ...
  82. [82]
    Early Pregnancy Loss: Background, Etiology, Pathophysiology
    Jul 31, 2025 · When these highly sensitive hCG assays are used early, the magnitude of pregnancy loss significantly increases to about 60-70%. Late ...Missing: empirical data
  83. [83]
    Incidence of early loss of pregnancy - PubMed - NIH
    Jul 28, 1988 · We identified 198 pregnancies by an increase in the hCG level near the expected time of implantation. Of these, 22 percent ended before ...
  84. [84]
    What is a biochemical pregnancy or miscarriage? - Instituto Bernabeu
    Biochemical pregnancy has an incidence of 13-22%, not varying whether fresh or vitrified embryos are transferred. The incidence is similar to that of the ...
  85. [85]
    Prospectively assessed perceived stress associated with early ... - NIH
    Aug 16, 2022 · Of the losses, 55 (29%) were hCG-detected losses and 133 (71%) were clinically recognized losses. There was no appreciable change in average ...Missing: empirical | Show results with:empirical
  86. [86]
    [PDF] Biochemical pregnancies: how should they be interpreted?
    The reported incidence of between 13-22% of pregnancies may be confounded as today's sensitive pregnancy tests may detect endometrial, pituitary or phantom hCG.
  87. [87]
    When a pregnancy fails early | Contemporary OB/GYN
    With a normal intrauterine pregnancy hCG is expected to rise by at least 53% over a 48-hour period, and a deviation from that trend may indicate a nonviable ...
  88. [88]
    Evaporation Line Pregnancy Test: Positive or Negative? - Healthline
    If you see an evaporation line on an at-home pregnancy test, you might be confused if you're expecting or not. Here's how to tell.How the test works · What is an evaporation line? · How to identify evaporation lineMissing: misinterpretation | Show results with:misinterpretation
  89. [89]
    The Causes For A False Positive Pregnancy Test - MEGA Lifesciences
    Jul 25, 2024 · False positive pregnancy tests can cause unnecessary stress, anxiety, and excitement. So to avoid such a state, understanding the potential for ...<|separator|>
  90. [90]
    Ectopic Pregnancy: Diagnosis and Management - AAFP
    May 15, 2020 · Beta human chorionic gonadotropin (β-hCG) can be detected in pregnancy as early as eight days after ovulation. The rate of increase in β-hCG ...Abstract · Making the Diagnosis · Management of Ectopic...
  91. [91]
    Ectopic Pregnancy hCG Levels: What You Need to Know
    Feb 2, 2023 · In a healthy pregnancy, the hCG level typically doubles every 48 hours. In an ectopic pregnancy, the hCG level may increase less than 66% in 48 hours.About Ectopic Pregnancy · Decoding hCG Levels · When hCG Levels Are Not...
  92. [92]
    Ectopic Pregnancy - StatPearls - NCBI Bookshelf
    Mar 27, 2025 · Ectopic pregnancy accounts for approximately 1% to 2% of pregnancies in the United States and 2% to 5% among patients who have utilized assisted ...
  93. [93]
    Ectopic Pregnancy: Practice Essentials, Background, Etiology
    Aug 9, 2024 · In ectopic pregnancies, β-HCG levels usually increase less. Mean serum β-HCG levels are lower in ectopic pregnancies than in healthy pregnancies ...
  94. [94]
    Hydatidiform Mole Workup - Medscape Reference
    Aug 5, 2024 · Quantitative beta-hCG levels: hCG levels greater than 100,000 mIU/mL indicate exuberant trophoblastic growth and raise suspicion for a molar ...
  95. [95]
    Molar Pregnancy: Types, Symptoms, Causes & Treatments
    In molar pregnancies, HCG is produced at abnormally high levels. A blood test can detect these high levels and suggest a molar pregnancy has occurred. Some ...
  96. [96]
    What serial hCG can tell you, and cannot tell you, about an early ...
    The serial measurement of serum hCG concentrations is an important clinical tool used to differentiate normal from abnormal pregnancies.
  97. [97]
    Early diagnosis and management of ectopic pregnancy
    Early diagnosis is the key to optimal treatment for ectopic pregnancy. Intervention prior to rupture prevents hemorrhage, potentially enhances fertility, and ...
  98. [98]
    Diagnosis and treatment of ectopic pregnancy
    Apr 3, 2021 · Early diagnosis of ectopic pregnancy is critical to reducing maternal mortality and improving treatment success rates, especially since many ...
  99. [99]
    Symptom‐free women at increased risk of ectopic pregnancy ...
    Jul 18, 2002 · Our model showed that screening for ectopic pregnancy is expected to reduce the probability of tubal rupture as compared with watchful waiting.
  100. [100]
    Diagnosis and treatment of ectopic pregnancy - PMC - NIH
    Ectopic pregnancy may present with rising, falling or plateau β-hCG levels; thus, serial measurement is most useful to confirm fetal viability rather than to ...
  101. [101]
    Beta hCG Levels in Ectopic Pregnancy - Dr.Oracle
    Aug 8, 2025 · There is no specific beta hCG level that definitively indicates an ectopic pregnancy, as ectopic pregnancies can occur with any beta hCG level.Beta Hcg Levels In Ectopic... · Diagnostic Approach · Atypical Beta Hcg Patterns...
  102. [102]
    High initial β-hCG predicts IVF outcomes accurately and ... - NIH
    Aug 9, 2023 · β-hCG is secreted from the cleaved embryo with 6–8 cells (2) and is expected to double every 1.4–2.1 days until 8–10 weeks of gestation (3, 4).
  103. [103]
    Tailoring clinical management after embryo transfer using β-hCG ...
    Jul 1, 2025 · Measuring β-hCG levels 12–18 days after embryo transfer (ET) has become a common practice to assess implantation success. However, the path from ...
  104. [104]
    What Is a Good Beta hCG Level After IVF? How to Understand Your ...
    Jun 26, 2025 · At around 10–14 days after embryo transfer, a beta hCG level above 100 mIU/mL is generally considered a strong result.Missing: serial protocols
  105. [105]
    Early β-hCG levels predict live birth after single embryo transfer - NIH
    Sep 8, 2022 · We hypothesized that a doubling of serum β-hCG over 48 h would be associated with an increased likelihood of live birth. Additionally, we ...
  106. [106]
    Initial β-hCG levels and 2-day-later increase rates effectively predict...
    Oct 20, 2023 · In this study, we found that initial β-hCG levels and their rate of increase 2 days later effectively predicted pregnancy outcomes following blastocyst ...
  107. [107]
    Abnormal human chorionic gonadotropin (hCG) trends after transfer ...
    Dec 19, 2017 · Serial measurements of hCG are the mainstay of monitoring these early pregnancies. Abnormal hCG trends, commonly defined as an hCG rise less ...
  108. [108]
    Egyptian Papyrus Reveals This Old Wives' Tale Is Very Old Indeed
    Aug 20, 2018 · The "Wheat and Barley" pregnancy test described in a recently translated medical text has been practiced for thousands of years.
  109. [109]
    From Cereal Grains to Immunochemistry—What Role Have ... - NIH
    Aug 31, 2023 · Ancient Egyptian physicians have rightly noticed that the best material for laboratory tests to detect pregnancy is urine [8]. Four thousand ...
  110. [110]
    Ancient Egyptian Pregnancy Test Survived Millennia Because It ...
    Feb 27, 2024 · Through empirical experimentation, they applied this knowledge to create a practical test, leveraging the natural properties of barley and wheat ...Missing: evidence | Show results with:evidence
  111. [111]
    8 Historical Methods of Detecting Pregnancy - Mental Floss
    Jun 8, 2023 · If the person's breath smelled of onions the next morning, they weren't pregnant; this was based on the idea that if the womb was open, and ...Missing: vinegar | Show results with:vinegar
  112. [112]
    Pregnancy test history 101 - Clearblue
    May 27, 2024 · In 1967, 26-year-old Margaret Crane designed the first home pregnancy test while designing packages for cosmetics at Organon Pharmaceuticals.
  113. [113]
    The Aschheim-Zondek Test for Pregnancy
    Sep 12, 2010 · Developed by German gynecologists Selmar Aschheim and Bernhard Zondek in 1927, the A-Z test was one of the first bioassays developed to detect ...
  114. [114]
    1927--the 1st demonstration of chorionic gonadotropin in the urine ...
    In memory of Aschheim and Zondek 50 years ago it is described the first detection of human chorionic gonadotropin (HCG) and so the first biologic pregnancy ...
  115. [115]
    The demand for pregnancy testing: The Aschheim–Zondek reaction ...
    Crucially, the Aschheim–Zondek reaction was a test not directly for the fetus, but for placental tissue. It was used, less as a yes-or-no test for ordinary ...
  116. [116]
    A Twenty-four Hour Pregnancy Test for Equines - Nature
    IN 1928 the Aschheim-Zondek Test for the diagnosis of human pregnancy in urine was introduced1. In 1930, B. Zondek proposed a modification of this test for ...
  117. [117]
    History of Pregnancy Testing
    The first immunoassay for hCG was the haemagglutination inhibition (HI) test, developed in 1960. Using purified hCG and antibodies directed towards hCG, urine ...
  118. [118]
    Pregnancy Tests | Embryo Project Encyclopedia
    Sep 2, 2010 · In 1966 A. R. Midgeley introduced a radioimmunoassay for hCG. Despite the new development, however, the radioimmunoassay suffered from the ...
  119. [119]
    History of Pregnancy Test | Encyclopedia MDPI
    Sep 11, 2023 · The test using the agglutination inhibition test was the first pregnancy test that successfully opened the way for tests for home use.Missing: pre- | Show results with:pre-<|control11|><|separator|>
  120. [120]
    A historical argument for regulatory failure in the case of Primodos ...
    Oct 23, 2018 · Predictor, the first reliable home test, debuted in 1971. It resembled a small chemistry set and was not an overnight commercial success ...
  121. [121]
    The Primodos components Norethisterone acetate and Ethinyl ...
    Feb 13, 2018 · Primodos was a hormone pregnancy test used between 1958–1978 that has been implicated with causing a range of birth defects ever since.
  122. [122]
    History of the Pregnancy Test - babyMed
    A. R. Midgley described the first radioimmunoassay for hCG, but the test still could not differentiate between hCG and luteinizing hormone. Several other ...
  123. [123]
    Before There Were Home Pregnancy Tests - The Atlantic
    Jun 17, 2015 · One of the oldest descriptions of a pregnancy test comes from ancient Egypt, where women who suspected they were pregnant would urinate on wheat ...<|separator|>
  124. [124]
    The surprising history of home pregnancy tests - Motherly
    Dec 23, 2021 · ... FDA approval in 1976, which was granted at the end of 1977. It was approved along with the Predictor, ACU-TEST and Answer. Pregnancy tests ...
  125. [125]
    Who Made That Home Pregnancy Test? - The New York Times
    Jul 27, 2012 · The first home pregnancy test, which appeared in drugstores in 1977, looked like a kid's chemistry set: it contained a vial of purified water, an angled mirror ...
  126. [126]
    The Home Pregnancy Test: A Feminist Technology? - Project MUSE
    Jun 3, 2009 · History of the Home Pregnancy Test​​ In 1976, the FDA approved four home pregnancy tests that were deemed "substantially equivalent" and by 1977, ...
  127. [127]
    Predictor Pregnancy Test - Design Prototype
    The Predictor test, invented by Margaret Crane, allowed women to test for pregnancy at home by adding urine to a solution and observing a dark brown circle. It ...<|separator|>
  128. [128]
    Testing times: the birth of the pregnancy test | Biomedical Scientist
    Jan 29, 2019 · Throughout the 1930s and 1940s, hormone-based research expanded and a number of laboratories developed bioassays to identify hCG – injecting ...Missing: isolation | Show results with:isolation
  129. [129]
    How an unknown designer created the first home pregnancy test in ...
    named Predictor — went on the market in Canada, and, after gaining FDA approval in 1976, in the United States ...
  130. [130]
    Home Pregnancy Tests - JSTOR Daily
    May 18, 2023 · Pharmaceutical companies saw a market, and the first home tests arrived on American drugstore shelves in 1977.
  131. [131]
    [PDF] The FDA's Restrictive Regulation of Home-Testing Devices
    Nov 13, 2017 · In the 1970s, the FDA briefly denied women access to home pregnancy tests that were identical to those used in laboratories. In the late 1980s ...
  132. [132]
    Pregnancy Tests: Digital Tests, Sticks and Kits - Clearblue
    Oct 14, 2025 · Clearblue pregnancy tests are over 99% accurate from the day of your expected period and can be used up to 5 days early.Missing: dipstick variations
  133. [133]
    [PDF] Comparison of accuracy and certainty of results of six home ...
    May 6, 2008 · This study further demonstrates how digital home pregnancy tests can deliver significant benefits to the consumer with respect to accuracy and.Missing: trials satisfaction
  134. [134]
    Digital Pregnancy Test Market Size & Share, Growth Forecasts 2037
    Jun 25, 2025 · Digital Pregnancy Test Market size was USD 1.6 billion in 2024 and is estimated to reach USD 2.5 billion by the end of 2037, expanding at a CAGR of 6.9% during ...
  135. [135]
    Take a Pregnancy Test With Your Phone? - Mom.com
    The First Response Pregnancy PRO digital pregnancy test can also be used as a pregnancy tracker, reminding you of doctor's appointments as well as your due date ...Missing: 2023-2025 | Show results with:2023-2025
  136. [136]
    Study Assessing the Usability and Patient Satisfaction With Digital ...
    300 pregnant women will be given a test kit and smartphone application during a clinic visit. Participants are instructed to conduct the test the next day.
  137. [137]
    The 6 Best Pregnancy Tests of 2025 | Reviews by Wirecutter
    Jan 7, 2025 · The inexpensive Wondfo Early Result wand test boasts a sensitivity of 10 mIU/mL and a 98% accuracy two days before an expected period, but the ...
  138. [138]
    5 Best Pregnancy Tests, Tested and Approved by Moms-to-Be
    Jul 29, 2025 · The Clearblue Early Detection test claims a 77 percent accuracy rate five days before your expected period—the second highest accuracy rating ...Missing: 2020-2025 | Show results with:2020-2025
  139. [139]
    HCG blood test - quantitative Information | Mount Sinai - New York
    Non-pregnant women: less than 5 mIU/mL; Healthy men: less than 2 mIU/mL. In pregnancy, HCG level rises rapidly during the first trimester and then declines ...
  140. [140]
    Pregnancy Detection Kits Market Trends, Opportunity, and Forecast ...
    Jul 4, 2025 · Digital pregnancy tests are gaining popularity due to their higher accuracy, easy-to-read digital outputs, and reduced risk of user error ...
  141. [141]
    Meta-analysis of intrauterine hCG perfusion efficacy in recurrent ...
    Jul 9, 2024 · This study evaluates the efficacy of intrauterine hCG perfusion for RIF, as defined by ESHRE 2023 guidelines, highlighting hCG as a cost-effective alternative ...Missing: 2020s | Show results with:2020s
  142. [142]
    The Effect of Serum β-Human Chorionic Gonadotropin on ...
    Sep 9, 2022 · High levels of β-hCG during pregnancy in singleton women are associated with a high incidence of pregnancy complications and adverse pregnancy outcomes.Missing: 2020s | Show results with:2020s
  143. [143]
    Reference ranges and determinants of total hCG levels during ...
    May 12, 2015 · We provide gestational RRs for total hCG and show that total hCG values and RR cut-offs during pregnancy vary depending on pregnancy dating methodology.
  144. [144]
    Hormone pregnancy tests - House of Commons Library
    Aug 15, 2024 · This review concluded that the available scientific evidence cannot causally link the use of hormone pregnancy tests and the development of ...
  145. [145]
    Professor Carl Heneghan presents research on controversial ...
    Dec 13, 2024 · His meta-analysis suggested a statistically significant correlation between hormone pregnancy tests and birth defects, a finding that challenges ...
  146. [146]
    Inaccurate Prenatal Tests Can Harm Expectant Parents, But ...
    Sep 6, 2022 · Noninvasive prenatal testing (NIPT) for five rare genetic conditions can return false positive results 80% to 93% of the time.
  147. [147]
    False-positives and false-negatives in non-invasive prenatal testing ...
    Aug 19, 2022 · While false positive rates of different NIPT tests maybe halfway accurate, reported false-negative rates are most likely too low.
  148. [148]
    A precise and rapid early pregnancy test: Development of a novel ...
    Mar 1, 2023 · We designed a precise, rapid and fully automatic device with an electrochemical point-of-care biosensor capable of quantitative hCG detection from human urine ...Missing: integrations research
  149. [149]
    Multimetallic Graphene-Coated THz Metasurface Biosensor for High ...
    Sep 11, 2025 · With such biorecognition integration, the device could provide reliable, label-free, and real-time quantification of hCG for pregnancy testing.
  150. [150]
    Feasibility and Acceptability of At-Home Routine Pregnancy Testing ...
    Among the sample, those with access to free urine pregnancy tests tested 93% of the time they suspected pregnancy, compared with 64% among those who did not ...Missing: ongoing | Show results with:ongoing